Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Conmed (CNMD)
NYSE:CNMD
Conmed (CNMD) Stock Price & Analysis
168 Followers
CNMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$61.05 - $137.65
Previous Close$70.75
Volume231.27K
Average Volume (3M)549.00K
Market Cap
$2.18B
Enterprise Value$3.19B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$1.01B
Price to Earnings (P/E)27.1
Beta1.30
Next Earnings
Jul 24, 2024EPS Estimate
$0.91Last Dividend Ex-Date
Mar 14, 2024Dividend Yield1.13%
Share Statistics
EPS (TTM)2.61
Shares Outstanding30,800,747
10 Day Avg. Volume897,859
30 Day Avg. Volume549,003
Standard Deviation0.11
R-Squared0.41
Alpha-0.00968
Financial Highlights & Ratios
Price to Book (P/B)-3.55
Price to Sales (P/S)2.08
Price to Cash Flow (P/CF)9.80
P/FCF Ratio9.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.73
Enterprise Value/Gross Profit5.59
Enterprise Value/Ebitda21.94
Forecast
1Y Price Target
$87.83Price Target Upside22.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Conmed News
PremiumCompany Announcements
Conmed Announces Executive Leadership Changes and Compensation Updates
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAnalysts highlight a stronger than expected quarterly gross margin, driven by a favorable product mix, showcasing the company's efficient cost management.
Product AdoptionThe significant growth in AirSeal placements demonstrates increasing adoption in laparoscopic surgeries, enhancing the company's market penetration.
Regulatory ApprovalThe FDA's 510(k) clearance for the company's advanced fifth-generation robotic system marks a notable achievement, potentially boosting its competitive edge in the medical technology field.
Bears Say
Financial GuidanceManagement lowered their revenue and EPS guidance due to a $10M incremental currency headwind and higher interest expense.
Growth SlowdownOrganic revenue growth slowed to 5.9% Y/Y in 1Q24 from 31.5% in 4Q23.
Product CompetitionInvestor concerns center on competition from the recently FDA-approved DV5 with a built-in insufflator, which may impact CNMD's market position.
---
Ownership Overview
2.82% Insiders
41.75% Mutual Funds
29.69% Other Institutional Investors
25.74% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CNMD FAQ
What was Conmed’s price range in the past 12 months?
Conmed lowest stock price was $61.05 and its highest was $137.65 in the past 12 months.
What is Conmed’s market cap?
Currently, no data Available
When is Conmed’s upcoming earnings report date?
Conmed’s upcoming earnings report date is Jul 24, 2024 which is in 77 days.
How were Conmed’s earnings last quarter?
Conmed released its earnings results on Apr 24, 2024. The company reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.738 by $0.052.
Is Conmed overvalued?
According to Wall Street analysts Conmed’s price is currently Undervalued.
Does Conmed pay dividends?
Conmed pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 1.13%. See more information on Conmed dividends here
What is Conmed’s EPS estimate?
Conmed’s EPS estimate is $0.91.
How many shares outstanding does Conmed have?
Conmed has 30,800,747 shares outstanding.
What happened to Conmed’s price movement after its last earnings report?
Conmed reported an EPS of $0.79 in its last earnings report, beating expectations of $0.738. Following the earnings report the stock price went down -11.584%.
Which hedge fund is a major shareholder of Conmed?
Among the largest hedge funds holding Conmed’s share is Fisher Asset Management LLC. It holds Conmed’s shares valued at 30M.
---
Conmed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$87.83 (22.58% Upside)
$87.83 (22.58% Upside)
Blogger Sentiment
Bullish
CNMD Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 13.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $204.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.14%
12-Months-Change
Fundamentals
Return on Equity
10.25%
Trailing 12-Months
Asset Growth
-0.47%
Trailing 12-Months
Company Description
Conmed
CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its product lines also include orthopedic surgey and general surgery. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Utica, NY.
---
CNMD Company Deck
---
CNMD Earnings Call
Q1 2024
0:00 / 0:00
---
CNMD Stock 12 Months Forecast
Average Price Target
$87.83
▲(22.58% Upside)
Technical Analysis
Best Analysts Covering CNMD
1 Year
1 Year Success Rate
10/21 ratings generated profit
1 Year Average Return
+4.40%
reiterated a buy rating 12 days ago
Copying Rick Wise's trades and holding each position for 1 Year would result in 47.62% of your transactions generating a profit, with an average return of +4.40% per trade.
---